Login / Signup

Real-world effectiveness of adalimumab in patients with moderate-to-severe hidradenitis suppurativa: the 1-year SOLACE study.

W GulliverA AlaviM C WisemanM J GooderhamJ RaoM S AlamKim A PappO DesjardinsC Jean
Published in: Journal of the European Academy of Dermatology and Venereology : JEADV (2021)
The effectiveness of adalimumab was maintained during this 1-year period, and an optimal gain was documented for patients with medium and high AN counts. These real-world data support a prompt treatment of HS patients and the use of IHS4 to monitor treatment.
Keyphrases